CDEK
← All organizations

Byondis

For profitWebsite ↗

Also known as: Byondis B.V. | Byondis B.V., The Netherlands | Synthon Biopharmaceuticals | Synthon Biopharmaceuticals BV | Synthon Biopharmaceuticals BV, The Netherlands | Synthon BV | SYNTHON BV | SYNTHON PHARMS | SYNTHON PHARMS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 1, 2011

First marketed drug

Jan 17, 2001

Last known activity

Jul 22, 2025

Defunct as of Jan 1, 2019

Timeline

1990s

  1. Jun 1, 1991

    Byondis— Founded

2000s

  1. May 25, 2007

    anastrozole— Marketing Organization

  2. Oct 9, 2007

    simvastatin— NDA Secondary Org

2010s

  1. Jun 23, 2011

    Syntarga— Acquired

  2. Jan 1, 2019

    Byondis— Defunct

Drugs by trial phase (10 distinct, 11 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (13)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (19)

Details

Founded
Nijmegen, NL Jun 1, 1991
Last known activity
Jul 22, 2025